Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes
Necroptosis has immunogenic cell death properties. Here, the authors show that the intra-tumor delivery of mRNA that codes for the necroptosis effector MLKL triggers neo-epitope-specific anti-tumor T cell responses and inhibits primary tumor growth and lung metastasis.
Guardado en:
Autores principales: | Lien Van Hoecke, Sandra Van Lint, Kenny Roose, Alexander Van Parys, Peter Vandenabeele, Johan Grooten, Jan Tavernier, Stefaan De Koker, Xavier Saelens |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/8238d6be45a64c8a92375d54457b3e83 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Cytotoxicity of crystals involves RIPK3-MLKL-mediated necroptosis
por: Shrikant R. Mulay, et al.
Publicado: (2016) -
MLKL trafficking and accumulation at the plasma membrane control the kinetics and threshold for necroptosis
por: Andre L. Samson, et al.
Publicado: (2020) -
Conformational interconversion of MLKL and disengagement from RIPK3 precede cell death by necroptosis
por: Sarah E. Garnish, et al.
Publicado: (2021) -
Human RIPK3 maintains MLKL in an inactive conformation prior to cell death by necroptosis
por: Yanxiang Meng, et al.
Publicado: (2021) -
Conformational switching of the pseudokinase domain promotes human MLKL tetramerization and cell death by necroptosis
por: Emma J. Petrie, et al.
Publicado: (2018)